FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review - Nasdaq
FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review Nasdaq
Sanofi SNY announced that the FDA has accepted for review its biologics license application (BLA) for MenQuadfi, a meningococcal vaccine.
Comments
Post a Comment